retatrutide triple agonist glp-1 gip glucagon phase 3 2025 First data, a Triumph of Science! From Obesity to Metabolic Health:

Unlike Rybelsus, which was the first oral GLP-1 medication but still a peptide, orforglipron is the first non-peptide oral GLP-1 receptor agonist

It is also understudied on whether folate supplements could be an effective treatment for psychiatric patients with defect MTHFR activity

Se integra en tu rutina en segundos

Discover how ethanol affects your treatment, what doctors recommend, and how PlexusDx personalizes your protocol

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to people with diabetes and those who are classified as morbidly obese.

Mood disorders, including major depressive disorder (MDD) and bipolar disorder (BD), are among the leading causes of disability worldwide and are frequently associated with treatment resistance, functional impairment, and high comorbidity with ...